Chen S, Li X, Shen Y, Lin S, Shui X, Zhu H
Regen Med. 2025; 20(1):35-44.
PMID: 40022525
PMC: 11881839.
DOI: 10.1080/17460751.2025.2469426.
Shweikeh F, Torres Y, Khan K, Mouchli M, Singh I
Immunol Res. 2025; 73(1):55.
PMID: 39979644
DOI: 10.1007/s12026-025-09608-7.
Feng C, Wang Z, Li C, Zhang X, Wang X
BMC Musculoskelet Disord. 2025; 26(1):44.
PMID: 39806324
PMC: 11727732.
DOI: 10.1186/s12891-025-08274-y.
Petrackova A, Horak P, Savara J, Skacelova M, Kriegova E
Front Immunol. 2025; 15:1505615.
PMID: 39744635
PMC: 11688219.
DOI: 10.3389/fimmu.2024.1505615.
Fritsch H, Giovanetti M, Clemente L, da Rocha Fernandes G, Fonseca V, de Lima M
Genes (Basel). 2024; 15(11).
PMID: 39596565
PMC: 11593632.
DOI: 10.3390/genes15111365.
Sulfasalazine-Induced Agranulocytosis: A Case Series and Review of Literature.
Chettri N, Mamadapur M, Subramanian R, Sandhya D, Kumar B R J
Mediterr J Rheumatol. 2024; 35(3):479-483.
PMID: 39463872
PMC: 11500113.
DOI: 10.31138/mjr.010124.sia.
Diagnostic Complexities and Management of Gouty Arthritis With Suspected Seronegative Rheumatoid Arthritis and Malignancy in an Elderly Male.
Keelapattu S, Bangaragiri A, Eada C
Cureus. 2024; 16(9):e68860.
PMID: 39376825
PMC: 11457434.
DOI: 10.7759/cureus.68860.
On difficulties to define prognostic factors for clinical practice in rheumatoid arthritis.
Vittecoq O, Brevet P, Gerard B, Lequerre T
RMD Open. 2024; 10(3).
PMID: 39343442
PMC: 11440182.
DOI: 10.1136/rmdopen-2024-004472.
Patient Characteristics and Outcomes Associated with Sentinel Protection Device Use in Patients with Aortic Valve Disease Undergoing TAVR in a "Real-World" Setting.
Jabagi H, Shaw R, Gharibeh L, Tayal R, Rahim H, Kim F
Rev Cardiovasc Med. 2024; 25(1):3.
PMID: 39077657
PMC: 11262339.
DOI: 10.31083/j.rcm2501003.
Impact of MTHFR gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients.
Mutlak Q, Kasim A
Sci Rep. 2024; 14(1):15119.
PMID: 38956106
PMC: 11219777.
DOI: 10.1038/s41598-024-65199-7.
Impact of TYMS gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients - identification of novel single nucleotide polymorphism: Cross-sectional study.
Mutlak Q, Kasim A, Aljanabi A
Medicine (Baltimore). 2024; 103(23):e38448.
PMID: 38847705
PMC: 11155610.
DOI: 10.1097/MD.0000000000038448.
Methylene Blue is a Monoamine Oxidase Inhibitor; Severe Harm and Death Associated with Low-Dose Methotrexate; Potentially Dangerous Mix-up between Cancer Drugs.
Cohen M, Smetzer J
Hosp Pharm. 2024; 51(2):110-114.
PMID: 38746770
PMC: 11089602.
DOI: 10.1310/hpj5102-110.
Preventive strategies to reduce the rate of periprosthetic infections in total joint arthroplasty; a comprehensive review.
Egerci O, Yapar A, Dogruoz F, Selcuk H, Kose O
Arch Orthop Trauma Surg. 2024; 144(12):5131-5146.
PMID: 38635048
PMC: 11602800.
DOI: 10.1007/s00402-024-05301-w.
Defining the key clinician skills and attributes for competency in managing patients with osteoporosis and fragility fractures.
Jackson L, Saag K, Johnson S, Danila M
J Bone Miner Res. 2024; 39(4):425-432.
PMID: 38477794
PMC: 11262141.
DOI: 10.1093/jbmr/zjae019.
Effect of acupuncture on ischaemic stroke in patients with rheumatoid arthritis: a nationwide propensity score-matched study.
Huang C, Huang M, Liao H, Lin C, Lee Y, Zimmerman G
BMJ Open. 2024; 14(2):e075218.
PMID: 38351113
PMC: 10868250.
DOI: 10.1136/bmjopen-2023-075218.
Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States.
Edgerton C, Frick A, Helfgott S, Huston K, Singh J, Zueger P
ACR Open Rheumatol. 2024; 6(4):179-188.
PMID: 38221639
PMC: 11016569.
DOI: 10.1002/acr2.11646.
Overview of Rheumatoid Arthritis and Scientific Understanding of the Disease.
Jahid M, Khan K, Rehan-Ul-Haq , Ahmed R
Mediterr J Rheumatol. 2023; 34(3):284-291.
PMID: 37941854
PMC: 10628871.
DOI: 10.31138/mjr.20230801.oo.
Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases.
Felis-Giemza A, Massalska M, Roszkowski L, Romanowska-Prochnicka K, Ciechomska M
J Inflamm Res. 2023; 16:3949-3965.
PMID: 37706062
PMC: 10497048.
DOI: 10.2147/JIR.S414739.
-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model.
Wang L, Huang B, Zeng Y, Yang J, Li Z, Ng J
Int J Biol Sci. 2023; 19(13):4082-4102.
PMID: 37705749
PMC: 10496504.
DOI: 10.7150/ijbs.85028.
Physicians' Agreement on and Implementation of the 2019 European Alliance of Associations for Rheumatology Vaccination Guideline: An International Survey.
Seo P, Winthrop K, Sawalha A, Choi S, Hwang W, Park H
J Rheum Dis. 2023; 30(1):18-25.
PMID: 37476523
PMC: 10351355.
DOI: 10.4078/jrd.22.0012.
